| 000 | 01634 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518042154.0 | ||
| 264 | 0 | _c20191230 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2072-6643 | ||
| 024 | 7 |
_a10.3390/nu11051185 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeng, Wendi | |
| 245 | 0 | 0 |
_aSulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis. _h[electronic resource] |
| 260 |
_bNutrients _cMay 2019 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCeramides _xbiosynthesis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen _xmetabolism |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin Receptor Substrate Proteins _xmetabolism |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aIsothiocyanates _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aPalmitic Acid _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aSerine C-Palmitoyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSulfoxides |
| 650 | 0 | 4 |
_aTriglycerides _xmetabolism |
| 700 | 1 | _aLi, Yuan | |
| 700 | 1 | _aDu, Min | |
| 700 | 1 | _aLei, Xingen | |
| 700 | 1 | _aXie, Siyu | |
| 700 | 1 | _aRen, Fazheng | |
| 773 | 0 |
_tNutrients _gvol. 11 _gno. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/nu11051185 _zAvailable from publisher's website |
| 999 |
_c29738439 _d29738439 |
||